The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
Hailey Meaklim,1,2 John Swieca,1 Moira Junge,1 Irena Laska,1 Danielle Kelly,1,3 Rosemarie Joyce,1,3 David Cunnington1 1Melbourne Sleep Disorders Centre, East Melbourne, VIC, Australia; 2Discipline of Psychology, RMIT University, Bundoora, VIC, Australia; 3Sleep Disorders Unit, St Vincent’s...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/208e029c48c44738b2296009fcbc4ae0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:208e029c48c44738b2296009fcbc4ae0 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:208e029c48c44738b2296009fcbc4ae02021-12-02T04:54:39ZThe DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment1179-1608https://doaj.org/article/208e029c48c44738b2296009fcbc4ae02018-11-01T00:00:00Zhttps://www.dovepress.com/the-dsm-5-self-rated-level-1-cross-cutting-symptom-measure-identifies--peer-reviewed-article-NSShttps://doaj.org/toc/1179-1608Hailey Meaklim,1,2 John Swieca,1 Moira Junge,1 Irena Laska,1 Danielle Kelly,1,3 Rosemarie Joyce,1,3 David Cunnington1 1Melbourne Sleep Disorders Centre, East Melbourne, VIC, Australia; 2Discipline of Psychology, RMIT University, Bundoora, VIC, Australia; 3Sleep Disorders Unit, St Vincent’s Private Hospital, East Melbourne and Werribee, VIC Australia Purpose: Referrals to sleep psychology services, even for a perceived single problem such as insomnia, can present with complex, coexistent psychiatric symptoms and comorbid disorders. This study aimed to assess the feasibility of implementing the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure (CCSM) into a sleep psychology clinic to identify coexistent psychiatric symptomatology in insomnia referrals. Patients and methods: Patients were 50 consecutive referrals to a private sleep psychology service within a sleep disorders center in Melbourne, Australia. Patients who attended sleep psychology services between June 2015 and January 2017 had their clinical records reviewed. Basic demographic information, comorbidities, and responses to the Insomnia Severity Index were gathered. The Diagnostic and Statistical Manual of Mental Disorders Ed. 5 Task Force and Work Groups created the CCSM in 2013 to deal with the issue of coexistent psychiatric symptomatology across mental health conditions, and this measure was included into the sleep psychology intake procedure and patient responses were reviewed. Results: The CCSM was simple and quick to administer and score and revealed high levels of psychiatric symptomatology in sleep psychology referrals. Sleep problems were the most common domain of psychiatric symptomatology reported (86%). Anxiety (66%), depression (64%), anger (64%), and somatic symptoms (50%) were also very common. Suicidal ideation was acknowledged by 26% of patients. In addition, 82% of patients had at least one diagnosed comorbidity upon referral (eg, psychiatric, physical health, or other sleep disorder). Conclusion: The findings support the CCSM as a feasible measure for identifying the high levels of coexistent psychiatric symptomatology in patients presenting for insomnia treatment at sleep psychology services. Keywords: comorbidity, sleep, mental health, insomnia, assessmentMeaklim HSwieca JJunge MLaska IKelly DJoyce RCunnington DDove Medical PressarticleComorbiditysleepmental healthinsomniaassessmentPsychiatryRC435-571Neurophysiology and neuropsychologyQP351-495ENNature and Science of Sleep, Vol Volume 10, Pp 377-383 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Comorbidity sleep mental health insomnia assessment Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495 |
| spellingShingle |
Comorbidity sleep mental health insomnia assessment Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495 Meaklim H Swieca J Junge M Laska I Kelly D Joyce R Cunnington D The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| description |
Hailey Meaklim,1,2 John Swieca,1 Moira Junge,1 Irena Laska,1 Danielle Kelly,1,3 Rosemarie Joyce,1,3 David Cunnington1 1Melbourne Sleep Disorders Centre, East Melbourne, VIC, Australia; 2Discipline of Psychology, RMIT University, Bundoora, VIC, Australia; 3Sleep Disorders Unit, St Vincent’s Private Hospital, East Melbourne and Werribee, VIC Australia Purpose: Referrals to sleep psychology services, even for a perceived single problem such as insomnia, can present with complex, coexistent psychiatric symptoms and comorbid disorders. This study aimed to assess the feasibility of implementing the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure (CCSM) into a sleep psychology clinic to identify coexistent psychiatric symptomatology in insomnia referrals. Patients and methods: Patients were 50 consecutive referrals to a private sleep psychology service within a sleep disorders center in Melbourne, Australia. Patients who attended sleep psychology services between June 2015 and January 2017 had their clinical records reviewed. Basic demographic information, comorbidities, and responses to the Insomnia Severity Index were gathered. The Diagnostic and Statistical Manual of Mental Disorders Ed. 5 Task Force and Work Groups created the CCSM in 2013 to deal with the issue of coexistent psychiatric symptomatology across mental health conditions, and this measure was included into the sleep psychology intake procedure and patient responses were reviewed. Results: The CCSM was simple and quick to administer and score and revealed high levels of psychiatric symptomatology in sleep psychology referrals. Sleep problems were the most common domain of psychiatric symptomatology reported (86%). Anxiety (66%), depression (64%), anger (64%), and somatic symptoms (50%) were also very common. Suicidal ideation was acknowledged by 26% of patients. In addition, 82% of patients had at least one diagnosed comorbidity upon referral (eg, psychiatric, physical health, or other sleep disorder). Conclusion: The findings support the CCSM as a feasible measure for identifying the high levels of coexistent psychiatric symptomatology in patients presenting for insomnia treatment at sleep psychology services. Keywords: comorbidity, sleep, mental health, insomnia, assessment |
| format |
article |
| author |
Meaklim H Swieca J Junge M Laska I Kelly D Joyce R Cunnington D |
| author_facet |
Meaklim H Swieca J Junge M Laska I Kelly D Joyce R Cunnington D |
| author_sort |
Meaklim H |
| title |
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| title_short |
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| title_full |
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| title_fullStr |
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| title_full_unstemmed |
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| title_sort |
dsm-5 self-rated level 1 cross-cutting symptom measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/208e029c48c44738b2296009fcbc4ae0 |
| work_keys_str_mv |
AT meaklimh thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT swiecaj thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT jungem thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT laskai thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT kellyd thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT joycer thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT cunningtond thedsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT meaklimh dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT swiecaj dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT jungem dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT laskai dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT kellyd dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT joycer dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment AT cunningtond dsm5selfratedlevel1crosscuttingsymptommeasureidentifieshighlevelsofcoexistentpsychiatricsymptomatologyinpatientsreferredforinsomniatreatment |
| _version_ |
1718400995964223488 |